The driving force in hospital formularies: economics versus efficacy.
The rising cost of pharmaceuticals has created a focus on hospital cost containment. From 1990 to 2000, spending on prescription drugs increased 200%. Through a variety of mechanisms and contracting, hospital formularies have become increasingly more restrictive. Physician choice with regard to antibiotics specifically is becoming more limited. The field of pharmacoeconomics looks at the cost effectiveness of the drugs we use. The pressures on the pharmaceutical industry and hospitals are reviewed here with a discussion of antibiotic prophylaxis, new expensive therapies, and physician responsibility. The driving force behind hospital formulary design is often economic, whereas the physician desires variety and efficacy. This review discusses some of the key issues related to drug costs and expenditures.
Franklin
Glen A
GA
Department of Surgery, Veterans Administration Medical Center and the University of Louisville, Louisville, Kentucky 40292, USA. glen.franklin@louisville.edu
D016527:Drug Costs; D017850:Economics, Pharmaceutical; D005572:Formularies, Hospital as Topic; D006801:Humans; D010819:Physician's Role; D012106:Research / Q000191:economics; D016896:Treatment Outcome